CFR Steps Back from India Buy
CFR Pharmaceuticals will withdraw its attempt to acquire 50% of India-based Stellence Pharmscience Private Limited, due to terms of...
Already have an account?
Subscribe now for unlimited access to all current and archive news, data and market analysis.
Take a free two-week trial now for the latest news, data and market analysis.